Nature, Published online: 09 October 2024; doi:10.1038/s41586-024-07943-7
Alterations in the tumour suppressor genes STK11 and/or KEAP1 can identify patients with advanced non-small-cell lung cancer who are likely to benefit from combinations of PD-(L)1 and CTLA4 immune checkpoint inhibitors added to chemotherapy.
Source link
Monica Contestabile 00:09Hello, this is How to Save Humanity in 17 Goals, a podcast brought…
An advanced ‘in memory’ computing chip developed by researchers from Princeton University, New Jersey, and…
Using Northern Hemisphere-specific seasonal language might not be inclusive to those in the Southern Hemisphere.Credit:…
Biodiversity is the variety and variability of life on Earth — and it is under…
As global leaders head to the U.N. Biodiversity Conference next week, a new report issued…
Illustration: David Parkins The problem Dear Nature, I’m a neuroscientist in the United States. I…